Novartis shifts Zolgensma manipulation blame to former AveXis execs

Brian and Allan Kaspar, who were executives at AveXis last year when Novartis acquired it for $8.7 billion, were named by the embattled drugmaker as being responsible for the data mishandling

Source: PharmaManufacturing.com - September 24, 2019 Category: Pharmaceuticals Source Type: news